Mir F. Alemdehy
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The Ig heavy chain protein but not its message controls early B cell development.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 24, 2020
Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology.
Journal: Oncotarget
Published: October 16, 2020
The Widely Used Antihelmintic Drug Albendazole is a Potent Inducer of Loss of Heterozygosity.
Journal: Frontiers in pharmacology
Published: August 19, 2020
The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8+ T cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 09, 2020
Transcriptome-wide analysis reveals insight into tumor suppressor functions of 1B3, a novel synthetic miR-193a-3p mimic.
Journal: Molecular therapy. Nucleic acids
Published: July 16, 2020
Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation.
Journal: EMBO reports
Published: June 26, 2020
Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L-dose dependency in HDAC1-deficient thymic lymphoma.
Journal: The EMBO journal
Published: January 15, 2019
Towards an understanding of C9orf82 protein/CAAP1 function.
Journal: PloS one
Published: October 16, 2018
MicroRNA-155 induces AML in combination with the loss of C/EBPA in mice.
Journal: Leukemia
Published: July 02, 2016
Stop the dicing in hematopoiesis: what have we learned?
Journal: Cell cycle (Georgetown, Tex.)
Published: July 18, 2012
Last Updated: 09/26/2026